Skip to Main Content
Try STAT+ TODAY
Trending:
Health
First Opinion
Biotech
STAT+
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Politics
STAT+

Democrats have their best shot yet at letting Medicare negotiate drug prices — but it’s still not a done deal

  • Nicholas Florko
  • Lev Facher

By Nicholas Florko and Lev Facher Jan. 11, 2021

Reprints
Democrat Drug Price Rebuttal
Sen. Chuck Schumer (D-N.Y.) will be the majority leader. AP Photo/Alex Brandon

WASHINGTON — Democrats have their best shot in more than a decade to deliver on one of the party’s central health care promises: allowing Medicare to directly negotiate prescription drug prices.

But it’s far from guaranteed that they can deliver.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Authors Reprints

Nicholas Florko

Nicholas Florko

Reporter, Commercial Determinants of Health

Nicholas Florko reports on the commercial determinants of health.

Lev Facher

Lev Facher

Addiction Reporter

Lev Facher covers the U.S. addiction and overdose crisis.

Tags

I was laid off from a public health job.…
I was laid off from a public health job. Trust me, tech layoffs are different
Promises — and pitfalls — of ChatGPT-assisted medicine
Promises — and pitfalls — of ChatGPT-assisted medicine
Eisai reports first U.S. sales of newly approved treatment…
Eisai reports first U.S. sales of newly approved treatment for Alzheimer’s disease
Turkish court hands Novartis and Roche a rare win…
Turkish court hands Novartis and Roche a rare win over their efforts to promote an eye…
Up and down the ladder: The latest comings and…
Up and down the ladder: The latest comings and goings
Pharmalittle: ALS Association and its chapters battle over money…
Pharmalittle: ALS Association and its chapters battle over money and priorities; eye drops recalled over links…

Recommended Stories